
Release date: 2026-03-31 17:08:17 Article From: Lucius Laos Recommended: 7
Awareness of these potential side effects helps patients identify them early and take timely intervention measures. However, it should be noted that the assessment and management of any side effects must be carried out under the professional guidance of a doctor.
Blood in urine or cloudy urine, burning, dryness or itching of the eyes, diarrhea, difficult, burning or painful urination, increased eye discharge or excessive tearing, fever, frequent urination, redness, pain or swelling of the eyes, eyelids or conjunctiva, redness, swelling or pain of the skin, skin peeling of the hands and feet, numbness of the hands and feet, skin ulcers.
Cough, dyspnea.
Blood in stools, black or tarry stools, heartburn, indigestion, nausea, severe abdominal pain, abdominal cramps or burning sensation in the abdomen, coffee-ground-like vomitus (with severe and persistent symptoms).
Seek immediate emergency medical attention if any of the following overdose symptoms occur during treatment:
Dizziness, headache, fatigue or weakness, abdominal pain, vomiting.
Skin blemishes, oral ulcers, chapped, red or swollen lips, decreased appetite, weight loss, dry skin, skin itching or rash, loose nails, nosebleeds, acne, redness or pain around the nails, runny nose, chapped, red, burning, painful or other inflammatory manifestations of the lips, ulcers or erosions on the lips, tongue or inside the mouth.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2072025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4432024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2132025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2312025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2072025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:2362025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2212025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2042025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: